Literature DB >> 12165144

Generation and characterization of polyclonal antibodies specific for human p110 sEGFR.

Trace A Christensen1, Jill L Reiter, Andre T Baron, Nita J Maihle.   

Abstract

The EGFR/ERBB family of receptor tyrosine kinases mediates intracellular signal transduction pathways important in the regulation of cell growth, differentiation, and transformation. We previously have reported the cloning and expression of a 3 kb alternative EGFR transcript which encodes a 110 kDa form of the receptor (p110 sEGFR). This receptor isoform is identical to the extracellular region of the full-length 170 kDa EGFR through amino acid 603; in addition, p110 sEGFR contains 78 unique carboxy-terminal amino acids. Here, we report the generation and characterization of polyclonal antisera specific for the unique carboxy-terminal sequence of p110 sEGFR. Polyclonal antisera were generated by immunizing rabbits with synthetic peptides corresponding to peptides contained within the unique carboxy-terminal sequence of p110 sEGFR. Immunoglobulin fractions from antisera which tested positive for immune reactivity to these peptides by ELISA were affinity-purified by protein G and peptide-based chromatography. This affinity-purified immunoglobulin fraction specifically recognizes p110 sEGFR by ELISA, immunoprecipitation, immunoblot analysis, and immunocytochemical methods. No cross-reactivity with full-length p170 EGFR is observed using any of these detection methods. These new polyclonal antibodies will be useful in determining the expression, localization, and function of p110 sEGFR, and importantly will allow us to distinguish between the expression of this receptor isoform and p170 EGFR.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12165144     DOI: 10.1089/153685902760173908

Source DB:  PubMed          Journal:  Hybrid Hybridomics        ISSN: 1536-8599


  4 in total

1.  Identification of immunoreactive regions of homology between soluble epidermal growth factor receptor and α5-integrin.

Authors:  Jason A Wilken; Andre T Baron; Ramsey A Foty; Daniel J McCormick; Nita J Maihle
Journal:  Biochemistry       Date:  2011-04-27       Impact factor: 3.162

2.  Reduced expression of the epidermal growth factor signaling system in preeclampsia.

Authors:  D R Armant; R Fritz; B A Kilburn; Y M Kim; J K Nien; N J Maihle; R Romero; R E Leach
Journal:  Placenta       Date:  2014-12-27       Impact factor: 3.481

3.  Analytic variability in immunohistochemistry biomarker studies.

Authors:  Valsamo K Anagnostou; Allison W Welsh; Jennifer M Giltnane; Summar Siddiqui; Camil Liceaga; Mark Gustavson; Konstantinos N Syrigos; Jill L Reiter; David L Rimm
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-23       Impact factor: 4.254

4.  EGFR isoforms and gene regulation in human endometrial cancer cells.

Authors:  Lina Albitar; Gavin Pickett; Marilee Morgan; Jason A Wilken; Nita J Maihle; Kimberly K Leslie
Journal:  Mol Cancer       Date:  2010-06-25       Impact factor: 27.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.